Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,656 public trials 2,147 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Completed

Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

NCT01034969

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Campbelltown Hospital Campbelltown, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Medizinische Universität Graz Graz, Austria
  • Faculdade de Medicina Do ABC Santo André, São Paulo, Brazil
View all 74 locations
View Trial Details
Completed

Pharmacokinetics of Oral Hydroxyurea Solution

NCT03763656

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations
  • Dr Angela E Rankine- Mullings Kingston, Jamaica
  • Birmingham Women's and Children's NHS Foundation Trust Birmingham, United Kingdom
  • Alder Hey Children's NHS Foundation Trust Liverpool, United Kingdom
  • Evelina London Children's Hospital London, United Kingdom
View Trial Details
Completed

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

NCT05432596

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Aclaris Investigational Site Birmingham, Alabama, United States
  • Aclaris Investigational Site Scottsdale, Arizona, United States
  • Aclaris Investigational Site Bryant, Arkansas, United States
  • Aclaris Investigational Site North Little Rock, Arkansas, United States
View all 32 locations
View Trial Details
Completed

AI Quantitative Coronary Angiography Versus Optical Coherent Tomography Guidance for Coronary Stent Implantation

NCT05388357

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • Sejong General Hospital Bucheon-si, South Korea
  • Keimyung University Dongsan Medical Center Daegu, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
  • GangNeung Asan Hospital Gangneung, South Korea
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

NCT03277196

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stanford University Palo Alto, California, United States
  • Alfred I DuPont Hospital for Children Wilmington, Delaware, United States
  • Nemours Children's Hospital Orlando, Florida, United States
View all 29 locations
View Trial Details
Completed

Open-label Study of Anakinra in MPS III

NCT04018755

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations
  • The Lundquist Institute at Harbor-UCLA Medical Center Torrance, California, United States
View Trial Details

Related conditions